These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10544566)
1. [The rapid diagnosis of toxigenic Vibrio cholerae strains in dot immunological analysis with monoclonal antibodies]. Devdariani ZL; Alenkina TA; Fedorova VA Klin Lab Diagn; 1999 Aug; (8):24, 33. PubMed ID: 10544566 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the ELISA method for cholera toxin determination in Vibrio cholerae cultures]. González-Bonilla C; Gutiérrez-Cogco L; Moguel-Pech L; Villanueva-Zamudio A Rev Latinoam Microbiol; 1994; 36(4):273-6. PubMed ID: 7701137 [TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody-based dot-blot ELISA diagnostic kit for the detection of Vibrio cholerae 01 in stools of diarrheic patients and household contacts. Supawat K; Huttayananont S; Kusum M; Kalambaheti T; Chaicumpa W Asian Pac J Allergy Immunol; 1994 Dec; 12(2):155-9. PubMed ID: 7612110 [TBL] [Abstract][Full Text] [Related]
8. [Comparative assessment of dot-immunoassay and immunochromatography methods for detection of 01 serogroup of vibrio cholerae]. Alekseeva LP; Telesmanich NR; Lomov IuM; Khramov MV; Kruglikov VD; Agafonova VV; Fateeva OF; Chebotarev DA; Kermanov AV Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):88-93. PubMed ID: 21381382 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Apter FM; Lencer WI; Finkelstein RA; Mekalanos JJ; Neutra MR Infect Immun; 1993 Dec; 61(12):5271-8. PubMed ID: 7693598 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262 [TBL] [Abstract][Full Text] [Related]
12. Differentiation among the Vibrio cholerae serotypes O1, O139, O141 and non-O1, non-O139, non-O141 using specific monoclonal antibodies with dot blotting. Pengsuk C; Longyant S; Rukpratanporn S; Chaivisuthangkura P; Sridulyakul P; Sithigorngul P J Microbiol Methods; 2011 Nov; 87(2):224-33. PubMed ID: 21851839 [TBL] [Abstract][Full Text] [Related]
13. Development of highly specific monoclonal antibodies for the diagnosis of Vibrio cholerae 01. Castillo L; Castillo D; Silva W; Zapata L; Reid M; Ulloa MT; Seoane M; Maldonado A; Valenzuela ME; Bustos R Hybridoma; 1995 Jun; 14(3):271-8. PubMed ID: 7590791 [TBL] [Abstract][Full Text] [Related]
14. [Potential use of serological methods in detecting cholera toxin]. Emdina IA; Alekseeva LP; Gritsenko AN; Somova AG; Bichul' KG Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):60-3. PubMed ID: 3124418 [TBL] [Abstract][Full Text] [Related]
15. Immunochromatographic detection of the heat-labile enterotoxin of enterotoxigenic Escherichia coli with cross-detection of cholera toxin. Arimitsu H; Sasaki K; Tsuji T J Microbiol Methods; 2017 Jan; 132():148-152. PubMed ID: 27940044 [TBL] [Abstract][Full Text] [Related]
16. Production and cross-reactivity patterns of a panel of high affinity monoclonal antibodies to Vibrio cholerae O139 Bengal. Garg S; Ramamurthy T; Mukhopadhyay AK; Deb BC; Nair GB; Shimada T; Takeda T; Huq A; Colwell RR; Takeda Y FEMS Immunol Med Microbiol; 1994 May; 8(4):293-8. PubMed ID: 8061653 [TBL] [Abstract][Full Text] [Related]
17. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059 [TBL] [Abstract][Full Text] [Related]
18. The impact of physico-chemical stress on the toxigenicity of Vibrio cholerae. Miller CJ; Drasar BS; Feachem RG; Hayes RJ J Hyg (Lond); 1986 Feb; 96(1):49-57. PubMed ID: 3950396 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the synthesis and specificity of enterotoxin from Vibrio cholerae O139 serotype using monoclonal antibodies]. Fedorova VA; Alenkina TV; Gromova OV; Devdariani EL; Dzhaparidze MN; Kosmoenko OM Mol Gen Mikrobiol Virusol; 1996; (3):3-6. PubMed ID: 8999316 [TBL] [Abstract][Full Text] [Related]
20. Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili. Dalsgaard A; Serichantalergs O; Forslund A; Lin W; Mekalanos J; Mintz E; Shimada T; Wells JG J Clin Microbiol; 2001 Nov; 39(11):4086-92. PubMed ID: 11682534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]